Laupacis, A. 2018. Evidence and Values: Requirements for Public Reimbursement of Drugs for Rare Diseases- A Case Study in Oncology- Reply. Journal of Population Therapeutics and Clinical Pharmacology. 16, 2 (Dec. 2018).